Copd.

Area of Science:

• Pulmonary Medicine
• Respiratory Health
• Clinical Evidence Synthesis

Background:

• Chronic obstructive pulmonary disease (COPD) is defined by irreversible airflow limitation, often progressive and linked to lung inflammation from irritant exposure.
• COPD commonly involves emphysema and chronic bronchitis, with smoking identified as the primary risk factor for its development and progression.

Purpose of the Study:

• To systematically review the effects of maintenance drug treatments in stable COPD.
• To assess the impact of smoking cessation interventions on individuals with stable COPD.
• To evaluate the efficacy of non-drug interventions for managing stable COPD.

Main Methods:

• Conducted a systematic review of medical literature up to April 2010, searching databases like Medline, Embase, and The Cochrane Library.
• Included 119 systematic reviews, randomized controlled trials (RCTs), and observational studies meeting predefined inclusion criteria.
• Incorporated safety alerts from regulatory bodies such as the US FDA and UK MHRA.

Main Results:

• The review identified and evaluated a wide range of interventions for stable COPD.
• A GRADE evaluation was performed to assess the quality of evidence for each intervention.
• Data from 119 studies were synthesized to provide comprehensive findings on COPD management.

Conclusions:

• Presents effectiveness and safety data for numerous COPD interventions.
• Interventions reviewed include alpha(1) antitrypsin, antibiotics, inhaled anticholinergics, inhaled beta(2) agonists, oral/inhaled corticosteroids, physical activity, inspiratory muscle training, nutritional support, mucolytics, long-term oxygen, muscle strength training, smoking cessation programs, pulmonary rehabilitation, and theophylline.
• Provides a consolidated evidence base for clinical decision-making in stable COPD management.